UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma

Roeschert, I; Poon, E; Henssen, AG; Garcia, HD; Gatti, M; Giansanti, C; Jamin, Y; ... Eilers, M; + view all (2021) Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma. Nature Cancer , 2 pp. 312-326. 10.1038/s43018-020-00171-8. Green open access

[thumbnail of EMS116978.pdf]
Preview
Text
EMS116978.pdf - Accepted Version

Download (6MB) | Preview

Abstract

Amplification of MYCN is the driving oncogene in a subset of high-risk neuroblastoma. The MYCN protein and the Aurora-A kinase form a complex during S phase that stabilizes MYCN. Here we show that MYCN activates Aurora-A on chromatin, which phosphorylates histone H3 at serine 10 in S phase, promotes the deposition of histone H3.3 and suppresses R-loop formation. Inhibition of Aurora-A induces transcription-replication conflicts and activates the Ataxia telangiectasia and Rad3 related (ATR) kinase, which limits double-strand break accumulation upon Aurora-A inhibition. Combined inhibition of Aurora-A and ATR induces rampant tumor-specific apoptosis and tumor regression in mouse models of neuroblastoma, leading to permanent eradication in a subset of mice. The therapeutic efficacy is due to both tumor cell-intrinsic and immune cell-mediated mechanisms. We propose that targeting the ability of Aurora-A to resolve transcription-replication conflicts is an effective therapy for MYCN-driven neuroblastoma (141 words).

Type: Article
Title: Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s43018-020-00171-8
Publisher version: https://doi.org/10.1038/s43018-020-00171-8
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10137684
Downloads since deposit
100Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item